SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-23-001544
Filing Date
2023-01-30
Accepted
2023-01-30 16:11:42
Documents
2
Period of Report
2023-01-26

Document Format Files

Seq Description Document Type Size
1 form3-01302023_090132.html 3  
1 form3-01302023_090132.xml 3 1745
2 ex24-01302023_090139.htm EX-24 6018
  Complete submission text file 0001415889-23-001544.txt   9323
Mailing Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087
Business Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087 484-801-4670
MARINUS PHARMACEUTICALS, INC. (Issuer) CIK: 0001267813 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ABEONA THERAPEUTICS INC. 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019
Business Address
Silverstein Christine Berni (Reporting) CIK: 0001772546 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36576 | Film No.: 23567850